Tissue Regenix Group plc Share Price
Equities
TRX
GB00BNTXR104
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
61 GBX | -0.81% | -0.81% | +17.31% |
03-19 | Tissue Regenix annual loss narrows sharply as revenue jumps | AN |
03-19 | Earnings Flash (TRX.L) TISSUE REGENIX GROUP Reports FY23 Revenue $29.5M | MT |
Sales 2024 * | 27.11M 33.95M 2.71B | Sales 2025 * | 31.03M 38.86M 3.1B | Capitalization | 43.3M 54.23M 4.33B |
---|---|---|---|---|---|
Net income 2024 * | - 0 0 | Net income 2025 * | - 0 0 | EV / Sales 2024 * | 1.69 x |
Net Debt 2024 * | 2.62M 3.28M 262M | Net Debt 2025 * | 3.84M 4.81M 384M | EV / Sales 2025 * | 1.52 x |
P/E ratio 2024 * |
-366
x | P/E ratio 2025 * |
147
x | Employees | 82 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 53.25% |
1 day | -0.81% | ||
1 week | -0.81% | ||
Current month | -2.40% | ||
3 months | +6.09% | ||
6 months | +7.96% | ||
Current year | +17.31% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Lee
CEO | Chief Executive Officer | 63 | 31/12/18 |
Kirsten Lund
DFI | Director of Finance/CFO | - | 31/12/09 |
David Cocke
DFI | Director of Finance/CFO | 58 | 20/01/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Trevor Phillips
BRD | Director/Board Member | 63 | 04/01/21 |
George Phillips
BRD | Director/Board Member | 64 | 04/01/21 |
Daniel Lee
CEO | Chief Executive Officer | 63 | 31/12/18 |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 61 | -0.81% | 3 500 |
26/04/24 | 61.5 | 0.00% | 61,694 |
25/04/24 | 61.5 | +2.16% | 53,466 |
24/04/24 | 60.2 | -2.11% | 47,682 |
23/04/24 | 61.5 | 0.00% | 19,970 |
Delayed Quote London S.E., April 29, 2024 at 08:13 am
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+17.31% | 53.94M | |
+4.36% | 32.47B | |
+16.51% | 7.45B | |
+21.71% | 3.89B | |
-16.29% | 3.17B | |
-25.96% | 1.28B | |
-36.14% | 1.09B | |
-35.42% | 902M | |
-0.13% | 893M | |
-24.12% | 857M |
- Stock Market
- Equities
- TRX Stock